A detailed history of Jpmorgan Chase & CO transactions in Generation Bio Co. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 170,192 shares of GBIO stock, worth $229,759. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170,192
Previous 173,694 2.02%
Holding current value
$229,759
Previous $489,000 14.11%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$2.16 - $3.51 $7,564 - $12,292
-3,502 Reduced 2.02%
170,192 $420,000
Q2 2024

Aug 12, 2024

SELL
$2.64 - $4.35 $249,173 - $410,570
-94,384 Reduced 35.21%
173,694 $489,000
Q1 2024

May 10, 2024

SELL
$1.73 - $4.07 $30,807 - $72,478
-17,808 Reduced 6.23%
268,078 $1.09 Million
Q4 2023

Feb 12, 2024

SELL
$0.91 - $3.35 $1.02 Million - $3.77 Million
-1,124,560 Reduced 79.73%
285,886 $471,000
Q3 2023

Nov 14, 2023

BUY
$3.65 - $6.9 $1.86 Million - $3.51 Million
509,129 Added 56.49%
1,410,446 $5.35 Million
Q2 2023

Aug 11, 2023

BUY
$3.5 - $5.67 $1.53 Million - $2.48 Million
437,463 Added 94.31%
901,317 $4.96 Million
Q1 2023

May 18, 2023

BUY
$3.61 - $7.01 $132,985 - $258,234
36,838 Added 8.63%
463,854 $1.99 Million
Q1 2023

May 11, 2023

SELL
$3.61 - $7.01 $123,187 - $239,209
-34,124 Reduced 7.4%
427,016 $1.84 Million
Q4 2022

Feb 13, 2023

BUY
$3.66 - $6.77 $11,217 - $20,750
3,065 Added 0.67%
461,140 $1.81 Million
Q3 2022

Nov 14, 2022

SELL
$4.68 - $8.34 $871,327 - $1.55 Million
-186,181 Reduced 28.9%
458,075 $2.43 Million
Q2 2022

Aug 11, 2022

SELL
$4.87 - $9.41 $78,012 - $150,738
-16,019 Reduced 2.43%
644,256 $4.23 Million
Q1 2022

May 11, 2022

BUY
$4.16 - $7.76 $408,803 - $762,575
98,270 Added 17.49%
660,275 $4.85 Million
Q4 2021

Feb 10, 2022

SELL
$5.99 - $24.97 $7.48 Million - $31.2 Million
-1,247,973 Reduced 68.95%
562,005 $3.98 Million
Q3 2021

Nov 12, 2021

BUY
$20.0 - $27.43 $36.2 Million - $49.6 Million
1,809,978 New
1,809,978 $45.4 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $79.7M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.